Age distribution of paediatric rotavirus gastroenteritis cases in Europe: The REVEAL† study

Scandinavian Journal of Infectious Diseases

Volumn 42, Issue 2, 2010, Pages 142-147

  Giaquinto, Carlo ^a   Van Damme, Pierre ^b  

^a UNIVERSITY OF PADOVA   (Italy)

^b UNIVERSITY OF ANTWERP   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE GASTROENTERITIS; AGE DISTRIBUTION; ARTICLE; CHILD; CHILDHOOD; COHORT ANALYSIS; COMMUNITY; CONTROLLED STUDY; EMERGENCY WARD; ENZYME LINKED IMMUNOSORBENT ASSAY; EUROPE; FEMALE; GASTROENTERITIS; GEOGRAPHIC DISTRIBUTION; HOSPITAL; HUMAN; INCIDENCE; INFANT; MAJOR CLINICAL STUDY; MALE; MEDICAL CARE; PRESCHOOL CHILD; PRIMARY MEDICAL CARE; PROSPECTIVE STUDY; ROTAVIRUS; ROTAVIRUS GASTROENTERITIS; VACCINATION;

AGE DISTRIBUTION; ANTIBODIES, VIRAL; CHILD, PRESCHOOL; COMMUNITY-ACQUIRED INFECTIONS; ENZYME-LINKED IMMUNOSORBENT ASSAY; EUROPE; FEMALE; GASTROENTERITIS; HUMANS; INCIDENCE; INFANT; MALE; PROSPECTIVE STUDIES; ROTAVIRUS; ROTAVIRUS INFECTIONS;

EID: 75749149702     PISSN: 00365548     EISSN: 16511980     Source Type: Journal    
DOI: 10.3109/00365540903380495     Document Type: Article

References (23)

1. Clark B, McKendrick M. A review of viral gastroenteritis. Curr Opin Infect Dis 2004;17:461-469
2. Leung AK, Kellner JD, Davies HD. Rotavirus gastroenteritis. Adv Ther 2005;22:476-487
3. Glass RI, Parashar UD, Bresee JS, Turcios R, Fischer TK, Widdowson MA, et al. Rotavirus vaccines: current prospects and future challenges. Lancet 2006;368:323-332
4. Van Damme P, Giaquinto C, Huet F, Gothefors L, Maxwell M, Van der Wielen M, on behalf of the REVEAL Study Group. Multicenter prospective study of the burden of rotavirus acute gastroenteritis in Europe, 2004-2005: the REVEAL Study. J Infect Dis 2007;195(Suppl 1):S4-16 (Pubitemid 46649601)
5. Clark H, Offit P. Vaccines for rotavirus gastroenteritis universally needed for infants. Pediatr Ann 2004;33:536-543
6. Parashar UD, Gibson CI, Bresse JS, Glass RI. Rotavirus and severe childhood diarrhea. Emerg Infect Dis 2006; 12:304-306
7. Soriano-Gabarró M, Mrukowicz J, Vesikari T, Verstraeten T. Burden of rotavirus disease in European Union countries. Pediatr Infect Dis J 2006;25(Suppl 1):S7-11
8. Giaquinto C, Van Damme P, Huet F, Gothefors L, Van der Wielen M, on behalf of the REVEAL Study Group. Costs of community-acquired pediatric rotavirus gastroenteritis in 7 European countries: the REVEAL Study. J Infect Dis 2007;195(Suppl 1):S36-44 (Pubitemid 46649604)
9. Bresee JS, Glass RI, Ivanoff B, Gentsch JR. Current status and future priorities for rotavirus vaccine development, evaluation and implementation in developing countries. Vaccine 1999;17:2207-2222
10. Forster J, Guarino A, Parez N, Moraga F, Roman E, Mory O, et al. Hospital-based surveillance to estimate the burden of rotavirus gastroenteritis among European children younger than 5 years of age. Pediatrics 2009;123:393-400
11. Gleizes O, Desselberger U, Tatochenko V, Rodrigo C, Salman N, Mezner Z, et al. Nosocomial rotavirus infection in European countries: a review of the epidemiology, severity and economic burden of hospital-acquired rotavirus disease. Pediatr Infect Dis J 2006;25(Suppl 1):S12-21
12. The Pediatric ROTavirus European CommitTee (PROTECT). The paediatric burden of rotavirus disease in Europe. Epidemiol Infect 2006;134:908-916
13. Meyer N, Diez-Domingo J, Baldo JM, Giaquinto C, Pazdiora P, Forster J, et al. Establishing primary care based surveillance to estimate the burden of rotavirus gastroenteritis in children aged <5 years in Europe. Abstract. Fifth Congress of the World Society for Pediatric Infectious Diseases (WSPID). Bangkok, Thailand, 15-18 November, 2007
14. International Epidemiological Association (IEA). Good epidemiological practice (GEP): proper conduct in epidemiologic research. IEA; June 2004. Available at: http://www. IEAWeb.org/GoodPract.htm (accessed 14 November 2006)
15. Ward RL, McNeal MM, Clemens JD, Sack, DA, Rao M, Huda N, et al. Reactivities of serotyping monoclonal antibodies with culture-adapted human rotaviruses. J Clin Microbiol 1991;29:449-456
16. Van Damme P, Giaquinto C, Maxwell M, Todd P, Van der Wielen M, on behalf of the REVEAL Study Group. Distribution of rotavirus genotypes in Europe, 2004-2005: the REVEAL Study. J Infect Dis 2007;195(Suppl 1):S17-25
17. Desenclos JC, Rebière I, Letrillard L, Flahault A, Hubert B. Diarrhoea-related morbidity and rotavirus infection in France. Acta Paediatr Suppl 1999;88:42-47
18. Franco MA, Angel J, Greenberg HB. Immunity and correlates of protection for rotavirus vaccines. Vaccine 2006;24:2718-2731
19. Cascio A, Vizzi E, Alaimo C, Arista S. Rotavirus gastroenteritis in Italian children: can severity of symptoms be related to the infecting virus? Clin Infect Dis 2001; 32:1126-1132
20. Raebel MA, Ou BS. Rotavirus disease and its prevention in infants and children. Pharmacotherapy 1999;19:1279-1295
21. Vesikari T, Van Damme P, Giaquinto C, Gray J, Mrukowicz J, Dagan R, et al. European Society for Paediatric Infectious Diseases/European Society for Paediatric Gastroenterology, Hepatology, and Nutrition evidence-based recommendations for rotavirus vaccination in Europe. J Pediatr Gastroenterol Nutr 2008;46(Suppl 2):S38-48
22. Vesikari T, Matson DO, Dennehy P, Van Damme P, Santosham M, Rodriguez Z, et al. Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine. N Engl J Med 2006;354:23-33 (Pubitemid 43048948)
23. Ruiz-Palacios GM, Pérez-Schael I, Velázquez FR, Abate H, Breuer T, Clemens SC, et al. Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis. N Engl J Med 2006;354:11-22